IE
TXG icon

Israel Englander’s 10x Genomics TXG Stock Holding History

Israel Englander’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$486K – 6492
2024
Q2 		$486K Sell
25,000
-5,000
-17% -$131K ﹤0.01% 4612
2024
Q1 		$1.13M Buy
30,000
+20,000
+200% +$879K ﹤0.01% 4195
2023
Q4 		$560K Buy
+10,000
New +$435K ﹤0.01% 4574
2022
Q3 		– Sell
-10,100
Closed -$457K – 7510
2022
Q2 		$457K Buy
+10,100
New +$524K ﹤0.01% 5031

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Israel Englander's TXG Position: Q2 2026 in Review

Israel Englander reduced its 10x Genomics (TXG) stake by 94% in Q2 2026, selling an estimated $51.1M and leaving 116,833 shares worth $4.48M. The position accounts for ﹤0.01% of the portfolio, ranked #3095.

Israel Englander first reported a position in TXG in Q3 2019 and has held it in 25 quarters since. The position peaked at $63.6M in Q3 2025. 389 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Israel Englander held 116,833 shares of 10x Genomics worth $4.48M as of Q2 2026.
  • Israel Englander sold 1,951,581 10x Genomics shares in Q2 2026, an estimated $51.1M.
  • 10x Genomics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3095 holding.
  • Israel Englander first reported a position in 10x Genomics in Q3 2019 and has held it in 25 quarters since.
  • Israel Englander's 10x Genomics position peaked at $63.6M in Q3 2025.
  • 389 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.